Cardiotoxicity in breast cancer treatment: Causes and mitigation

被引:9
作者
Valiyaveettil, Deepthi [1 ]
Joseph, Deepa [2 ]
Malik, Monica [1 ]
机构
[1] Nizams Inst Med Sci, Hyderabad, India
[2] All India Inst Med Sci, Dept Radiat Oncol, Rishikesh, India
关键词
Breast cancer; Cardiotoxicity; Chemotherapy; Radiotherapy; Treatment side effect; PERTUZUMAB PLUS TRASTUZUMAB; CORONARY-ARTERY STENOSIS; INDUCED CARDIAC TOXICITY; LONG-TERM SURVIVORS; FOLLOW-UP; ADJUVANT TRASTUZUMAB; RADIATION-THERAPY; HEART-FAILURE; ANTHRACYCLINE CARDIOTOXICITY; AMERICAN SOCIETY;
D O I
10.1016/j.ctarc.2023.100760
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Survivorship issues and treatment related toxicities have considerably increased in breast cancer patients following improved therapeutic options. Cardiotoxicity has been a major treatment related side effects in these patients. Despite this being a well-known entity, the real magnitude of the problem remains an enigma. The amount of research in mitigation of cardiotoxicity or its management in breast cancer survivors is limited and there is an urgent need for finding solutions for the problem. In this article, we are reviewing the agents that cause cardiotoxicity and suggesting a proposal for follow up of breast cancer survivors in an attempt to reduce the magnitude of impact on their quality of life.
引用
收藏
页数:8
相关论文
共 129 条
  • [1] Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy
    Adams, MJ
    Lipsitz, SR
    Colan, SD
    Tarbell, NJ
    Treves, ST
    Diller, L
    Greenbaum, N
    Mauch, P
    Lipshultz, SE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3139 - 3148
  • [2] Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial
    Advani, Pooja P.
    Ballman, Karla V.
    Dockter, Travis J.
    Colon-Otero, Gerardo
    Perez, Edith A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) : 581 - +
  • [3] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
    Albain, K.
    Anderson, S.
    Arriagada, R.
    Barlow, W.
    Bergh, J.
    Bliss, J.
    Buyse, M.
    Cameron, D.
    Carrasco, E.
    Clarke, M.
    Correa, C.
    Coates, A.
    Collins, R.
    Costantino, J.
    Cutter, D.
    Cuzick, J.
    Darby, S.
    Davidson, N.
    Davies, C.
    Davies, K.
    Delmestri, A.
    Di Leo, A.
    Dowsett, M.
    Elphinstone, P.
    Evans, V.
    Ewertz, M.
    Gelber, R.
    Gettins, L.
    Geyer, C.
    Goldhirsch, A.
    Godwin, J.
    Gray, R.
    Gregory, C.
    Hayes, D.
    Hill, C.
    Ingle, J.
    Jakesz, R.
    James, S.
    Kaufmann, M.
    Kerr, A.
    MacKinnon, E.
    McGale, P.
    McHugh, T.
    Norton, L.
    Ohashi, Y.
    Paik, S.
    Pan, H. C.
    Perez, E.
    Peto, R.
    Piccart, M.
    [J]. LANCET, 2012, 379 (9814) : 432 - 444
  • [4] Aleman Berthe M P, 2014, EJC Suppl, V12, P18, DOI 10.1016/j.ejcsup.2014.03.002
  • [5] Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis
    Alhussein, Muhammad Mustafa
    Mokbel, Abir
    Cosman, Tammy
    Aghel, Nazanin
    Yang, Eric H.
    Mukherjee, Som D.
    Dent, Susan
    Ellis, Peter M.
    Dhesy-Thind, Sukhbinder
    Leong, Darryl P.
    [J]. CJC OPEN, 2021, 3 (11) : 1372 - 1382
  • [6] An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity
    Anjos, Miguel
    Fontes-Oliveira, Marta
    Costa, Vera M.
    Santos, Mario
    Ferreira, Rita
    [J]. LIFE SCIENCES, 2021, 280
  • [7] Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
    Armenian, Saro H.
    Lacchetti, Christina
    Barac, Ana
    Carver, Joseph
    Constine, Louis S.
    Denduluri, Neelima
    Dent, Susan
    Douglas, Pamela S.
    Durand, Jean-Bernard
    Ewer, Michael
    Fabian, Carol
    Hudson, Melissa
    Jessup, Mariell
    Jones, Lee W.
    Ky, Bonnie
    Mayer, Erica L.
    Moslehi, Javid
    Oeffinger, Kevin
    Ray, Katharine
    Ruddy, Kathryn
    Lenihan, Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08) : 893 - U144
  • [8] Screening Adult Survivors of Childhood Cancer for Cardiomyopathy: Comparison of Echocardiography and Cardiac Magnetic Resonance Imaging
    Armstrong, Gregory T.
    Plana, Juan Carlos
    Zhang, Nan
    Srivastava, Deokumar
    Green, Daniel M.
    Ness, Kirsten K.
    Donovan, F. Daniel
    Metzger, Monika L.
    Arevalo, Alejandro
    Durand, Jean-Bernard
    Joshi, Vijaya
    Hudson, Melissa M.
    Robison, Leslie L.
    Flamm, Scott D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (23) : 2876 - 2884
  • [9] THE USE OF A SPECIFIC HYPOFRACTIONATED RADIATION-THERAPY REGIMEN VERSUS CLASSICAL FRACTIONATION IN THE TREATMENT OF BREAST-CANCER - A RANDOMIZED STUDY OF 230 PATIENTS
    BAILLET, F
    HOUSSET, M
    MAYLIN, C
    BOISSERIE, G
    BETTAHAR, R
    DELANIAN, S
    HABIB, F
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (05): : 1131 - 1133
  • [10] Cardiovascular Toxicities of Immune Checkpoint Inhibitors JACC Review Topic of the Week
    Ball, Somedeb
    Ghosh, Raktim K.
    Wongsaengsak, Sariya
    Bandyopadhyay, Dhrubajyoti
    Ghosh, Gopal Chandra
    Aronow, Wilbert S.
    Fonarow, Gregg C.
    Lenihan, Daniel J.
    Bhatt, Deepak L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : 1714 - 1715